DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▼ |
---|---|---|---|---|---|
C0007137 | Squamous cell carcinoma | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0011860 | Diabetes Mellitus, Non-Insulin-Dependent | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0001418 | Adenocarcinoma | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0392006 | Unilateral cleft lip | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0041696 | Unipolar Depression | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C1332986 | Childhood Osteosarcoma | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C4721806 | Carcinoma, Basal Cell | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0684249 | Carcinoma of lung | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0007114 | Malignant neoplasm of skin | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0007131 | Non-Small Cell Lung Carcinoma | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0585442 | Osteosarcoma of bone | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C1269683 | Major Depressive Disorder | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C0476089 | Endometrial Carcinoma | TNKS2 | 80351 | tankyrase 2 | Q9H2K2 |
C1843116 | Bile acid synthesis defect, congenital, 1 | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0005779 | Blood Coagulation Disorders | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C2931067 | Cholestasis, progressive familial intrahepatic 4 | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0268312 | Progressive intrahepatic cholestasis (disorder) | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0038238 | Steatorrhea | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0008370 | Cholestasis | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0024523 | Malabsorption Syndrome | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0011991 | Diarrhea | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0020433 | Hyperbilirubinemia | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0030567 | Parkinson Disease | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0023895 | Liver diseases | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
C0027651 | Neoplasms | HSD3B7 | 80270 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7 | Q9H2F3 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024